PENICILLIN G

PENICILLIN G was reported 2352 times

PENICILLIN G is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAPILLARITIS 24 0.0870
1 SINOBRONCHITIS 12 0.0805
2 SPINAL MUSCULAR ATROPHY 20 0.0741
3 TOTAL LUNG CAPACITY ABNORMAL 28 0.0720
4 HEPATITIS INFECTIOUS MONONUCLEOSIS 6 0.0619
5 PULMONARY VASCULITIS 29 0.0539
6 MULTIPLE DRUG HYPERSENSITIVITY 5 0.0521
7 STOMA CLOSURE 16 0.0514
8 SPIROMETRY ABNORMAL 29 0.0485
9 MITE ALLERGY 31 0.0473
10 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 34 0.0464
11 MOTOR NEURONE DISEASE 19 0.0390
12 RESPIRATORY TRACT INFECTION BACTERIAL 19 0.0382
13 CONGENITAL SYPHILIS 2 0.0377
14 PNEUMOCOCCAL SEPSIS 24 0.0365
15 MYCOTIC ALLERGY 31 0.0363
16 SALPINGO-OOPHORECTOMY BILATERAL 7 0.0347
17 POSITIVE AIRWAY PRESSURE THERAPY 10 0.0342
18 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 15 0.0327
19 DUST ALLERGY 31 0.0316
20 TOXIC SHOCK SYNDROME STREPTOCOCCAL 6 0.0311
21 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 15 0.0294
22 OESOPHAGEAL SPASM 54 0.0293
23 C-REACTIVE PROTEIN DECREASED 18 0.0276
24 CARCINOID CRISIS 6 0.0265
25 SPINAL CORD ABSCESS 7 0.0256
26 LOSS OF EMPLOYMENT 73 0.0241
27 MYCOTIC ANEURYSM 2 0.0238
28 PNEUMOCOCCAL INFECTION 14 0.0236
29 FOETAL HEART RATE INCREASED 2 0.0227
30 ENCEPHALITIS FUNGAL 2 0.0222
31 MUCOSA VESICLE 2 0.0222
32 JARISCH-HERXHEIMER REACTION 15 0.0211
33 CARCINOGENICITY 5 0.0207
34 CONJUNCTIVITIS ALLERGIC 30 0.0202
35 NEURITIS 31 0.0201
36 CONGENITAL PULMONARY ARTERY ANOMALY 2 0.0196
37 CHRONIC TONSILLITIS 3 0.0196
38 ISCHAEMIC CEREBRAL INFARCTION 22 0.0189
39 ANAEMIA NEONATAL 9 0.0187
40 LACTOBACILLUS INFECTION 3 0.0183
41 INTESTINAL BARRIER DYSFUNCTION 2 0.0172
42 OBSTRUCTIVE SLEEP APNOEA SYNDROME 25 0.0171
43 MARROW HYPERPLASIA 11 0.0161
44 CYSTATIN C INCREASED 2 0.0156
45 LYMPHADENECTOMY 15 0.0154
46 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 31 0.0152
47 NEPHROSTOMY 5 0.0152
48 PALPABLE PURPURA 4 0.0146
49 ALLERGIC SINUSITIS 12 0.0140
50 OESOPHAGEAL PAIN 55 0.0139
51 LUDWIG ANGINA 2 0.0139
52 NEUROSYPHILIS 2 0.0132
53 BRONCHIAL DISORDER 20 0.0129
54 KERATITIS BACTERIAL 2 0.0123
55 CONGENITAL CORONARY ARTERY MALFORMATION 2 0.0118
56 RESPIRATORY SYMPTOM 32 0.0112
57 BASE EXCESS DECREASED 2 0.0112
58 MUSCLE MASS 5 0.0111
59 BRONCHIAL OBSTRUCTION 15 0.0107
60 NORMOCHROMIC NORMOCYTIC ANAEMIA 32 0.0106
61 FORCED EXPIRATORY VOLUME DECREASED 30 0.0106
62 URETEROLITHIASIS 11 0.0105
63 SPUTUM INCREASED 22 0.0102
64 INFANTILE VOMITING 2 0.0101
65 EYE EXCISION 2 0.0098
66 NEONATAL TACHYPNOEA 4 0.0097
67 RESUSCITATION 16 0.0096
68 CEREBRAL HAEMORRHAGE NEONATAL 2 0.0094
69 LYMPHOEDEMA 60 0.0087
70 PLEOCYTOSIS 5 0.0086
71 INFANTILE APNOEIC ATTACK 2 0.0085
72 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 3 0.0085
73 ORAL SURGERY 20 0.0085
74 SCIATIC NERVE INJURY 7 0.0084
75 TENDON OPERATION 4 0.0083
76 MEAN PLATELET VOLUME INCREASED 5 0.0083
77 CLOSTRIDIAL SEPSIS 2 0.0083
78 FINE MOTOR DELAY 2 0.0079
79 INCREASED BRONCHIAL SECRETION 20 0.0078
80 PRECANCEROUS CONDITION 5 0.0075
81 CHEST X-RAY ABNORMAL 22 0.0072
82 LUNG CONSOLIDATION 20 0.0071
83 OMPHALITIS 2 0.0071
84 GROSS MOTOR DELAY 2 0.0070
85 COMPLICATION OF DELIVERY 2 0.0069
86 DOUBLE OUTLET RIGHT VENTRICLE 2 0.0068
87 FUNGAL ENDOCARDITIS 2 0.0066
88 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 11 0.0065
89 HYPERTROPHIC CARDIOMYOPATHY 10 0.0065
90 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 8 0.0063
91 LISTERIOSIS 7 0.0063
92 SPLENIC INFARCTION 11 0.0063
93 LYMPHADENITIS 15 0.0062
94 SEPSIS NEONATAL 5 0.0062
95 IDIOSYNCRATIC DRUG REACTION 6 0.0061
96 IODINE ALLERGY 2 0.0060
97 NEUROLOGICAL SYMPTOM 34 0.0059
98 NEONATAL RESPIRATORY FAILURE 3 0.0059
99 MECHANICAL VENTILATION 11 0.0058
100 HEPATIC STEATOSIS 107 0.0057
101 PULMONARY ALVEOLAR HAEMORRHAGE 32 0.0057
102 CONVULSION NEONATAL 3 0.0057
103 DENTAL RESTORATION FAILURE 4 0.0055
104 NEONATAL HYPOTENSION 2 0.0054
105 RETINOPATHY OF PREMATURITY 3 0.0054
106 JOINT ANKYLOSIS 3 0.0053
107 HYPERBILIRUBINAEMIA NEONATAL 3 0.0052
108 GRUNTING 3 0.0050
109 NECROTISING ENTEROCOLITIS NEONATAL 2 0.0049
110 HYPOXIC ENCEPHALOPATHY 2 0.0049
111 CEREBRAL ISCHAEMIA 25 0.0049
112 ARTERIOSCLEROSIS CORONARY ARTERY 32 0.0048
113 APGAR SCORE LOW 6 0.0047
114 DEMYELINATION 19 0.0046
115 DISEASE COMPLICATION 21 0.0046
116 ANAEMIA MEGALOBLASTIC 2 0.0045
117 LAPAROTOMY 2 0.0044
118 CEREBRAL CYST 3 0.0044
119 INTESTINAL ISCHAEMIA 24 0.0044
120 SKIN TEST POSITIVE 4 0.0043
121 FUSARIUM INFECTION 3 0.0043
122 WRIST SURGERY 4 0.0043
123 ENDOTRACHEAL INTUBATION 12 0.0043
124 INFUSION SITE INFLAMMATION 3 0.0042
125 ACTINOMYCOSIS 4 0.0042
126 BLOOD BICARBONATE INCREASED 2 0.0042
127 CARDIAC VALVE VEGETATION 2 0.0041
128 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 32 0.0041
129 ORAL DISORDER 30 0.0041
130 ERYSIPELAS 20 0.0040
131 X-RAY ABNORMAL 7 0.0039
132 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 5 0.0038
133 NEONATAL DISORDER 6 0.0038
134 ANAL ATRESIA 2 0.0037
135 INFANTILE APNOEA 3 0.0037
136 DYSBIOSIS 3 0.0037
137 MYELOFIBROSIS 11 0.0036
138 BONE FRAGMENTATION 2 0.0036
139 CONTRAINDICATED PRODUCT ADMINISTERED 107 0.0035
140 METABOLIC DISORDER 20 0.0034
141 INCISION SITE PAIN 4 0.0034
142 ARTERIOSCLEROSIS 32 0.0034
143 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 57 0.0034
144 MIGRAINE WITH AURA 9 0.0033
145 FULL BLOOD COUNT ABNORMAL 35 0.0033
146 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
147 BRADYCARDIA NEONATAL 4 0.0032
148 PRODUCT USED FOR UNKNOWN INDICATION 4 0.0032
149 AUTOIMMUNE THYROIDITIS 12 0.0032
150 NEPHRITIS INTERSTITIAL 4 0.0032
151 URINARY TRACT INFECTION BACTERIAL 8 0.0032
152 NECROTISING COLITIS 4 0.0032
153 PROSTATE INFECTION 3 0.0031
154 NEONATAL RESPIRATORY DISTRESS SYNDROME 11 0.0031
155 HYPERVIGILANCE 3 0.0031
156 ATELECTASIS 30 0.0031
157 PERIARTHRITIS 7 0.0031
158 SCOLIOSIS 19 0.0031
159 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
160 SLEEP APNOEA SYNDROME 57 0.0030
161 ESCHERICHIA BACTERAEMIA 7 0.0030
162 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 19 0.0029
163 ABSCESS JAW 3 0.0029
164 FEEDING DISORDER NEONATAL 3 0.0029
165 BONE DEMINERALISATION 3 0.0028
166 ANTICONVULSANT DRUG LEVEL DECREASED 4 0.0028
167 OBSTRUCTIVE AIRWAYS DISORDER 31 0.0028
168 CARDIAC ENZYMES INCREASED 2 0.0028
169 CHYLOTHORAX 2 0.0028
170 ARTERIAL HAEMORRHAGE 3 0.0026
171 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 6 0.0026
172 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
173 POLYDACTYLY 3 0.0026
174 UTERINE DISORDER 6 0.0026
175 VASCULITIS 30 0.0026
176 BILIRUBIN CONJUGATED INCREASED 6 0.0026
177 THERAPEUTIC PRODUCT EFFECT DECREASED 114 0.0025
178 RHEUMATOID NODULE 7 0.0025
179 EMBOLIA CUTIS MEDICAMENTOSA 2 0.0025
180 MAMMOPLASTY 2 0.0025
181 LUNG INFILTRATION 22 0.0025
182 FIBROMYALGIA 60 0.0025
183 OXYGEN SATURATION ABNORMAL 7 0.0025
184 HAEMOLYSIS 19 0.0025
185 CRYPTOCOCCOSIS 4 0.0025
186 NODULE 32 0.0024
187 NASAL POLYPS 12 0.0024
188 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
189 BRADYCARDIA FOETAL 2 0.0024
190 INFUSION SITE IRRITATION 3 0.0023
191 GINGIVAL ERYTHEMA 2 0.0023
192 AXONAL NEUROPATHY 2 0.0023
193 ECTOPIC PREGNANCY 7 0.0023
194 CLOSTRIDIUM TEST POSITIVE 5 0.0023
195 EXTENSOR PLANTAR RESPONSE 2 0.0022
196 MOTOR DYSFUNCTION 22 0.0022
197 BONE DENSITY ABNORMAL 8 0.0021
198 FOETAL GROWTH RESTRICTION 13 0.0021
199 PRURITUS GENITAL 5 0.0021
200 OLIGOHYDRAMNIOS 7 0.0021
201 SERUM FERRITIN INCREASED 11 0.0021
202 NOROVIRUS INFECTION 3 0.0021
203 BONE SWELLING 2 0.0021
204 MATERNAL EXPOSURE DURING DELIVERY 2 0.0020
205 BRAIN INJURY 20 0.0020
206 GASTRECTOMY 2 0.0020
207 DRUG INTOLERANCE 192 0.0020
208 NECROTISING FASCIITIS 7 0.0020
209 FALSE POSITIVE INVESTIGATION RESULT 2 0.0020
210 SYNOVITIS 35 0.0019
211 OSTEOSCLEROSIS 3 0.0019
212 BLOOD URIC ACID INCREASED 11 0.0019
213 CYSTITIS 60 0.0019
214 HYDRONEPHROSIS 14 0.0019
215 INFUSION SITE BRUISING 4 0.0019
216 HEPATIC NEOPLASM 6 0.0018
217 TACHYPNOEA 25 0.0018
218 NOSOCOMIAL INFECTION 4 0.0018
219 TENOSYNOVITIS 5 0.0018
220 SKIN MASS 12 0.0018
221 PULMONARY FIBROSIS 34 0.0018
222 CIRCULATORY COLLAPSE 30 0.0018
223 HAEMATOCRIT INCREASED 4 0.0018
224 BLOOD PH DECREASED 3 0.0018
225 MUSCLE ATROPHY 22 0.0017
226 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
227 DERMATITIS EXFOLIATIVE GENERALISED 6 0.0017
228 MENINGITIS CRYPTOCOCCAL 3 0.0017
229 TYPE I HYPERSENSITIVITY 6 0.0017
230 GROIN ABSCESS 2 0.0017
231 LIPASE INCREASED 13 0.0017
232 ESCHERICHIA TEST POSITIVE 2 0.0017
233 PREMATURE RUPTURE OF MEMBRANES 4 0.0017
234 SYSTEMIC CANDIDA 4 0.0016
235 SPUTUM DISCOLOURED 15 0.0016
236 GINGIVAL DISORDER 6 0.0016
237 MEAN CELL VOLUME INCREASED 4 0.0016
238 POOR VENOUS ACCESS 16 0.0015
239 PSEUDOMONAS INFECTION 13 0.0015
240 LOW BIRTH WEIGHT BABY 12 0.0015
241 LEUKOCYTOSIS 27 0.0015
242 ANAPHYLACTIC REACTION 81 0.0015
243 CAESAREAN SECTION 17 0.0015
244 ABSCESS ORAL 2 0.0015
245 HUMERUS FRACTURE 7 0.0015
246 ENTEROCOCCAL INFECTION 7 0.0014
247 HYPOSPADIAS 3 0.0014
248 SECRETION DISCHARGE 18 0.0014
249 PSYCHOMOTOR RETARDATION 4 0.0014
250 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
251 GENITAL RASH 2 0.0014
252 LIVER DISORDER 62 0.0014
253 MENINGITIS BACTERIAL 2 0.0014
254 INVESTIGATION ABNORMAL 2 0.0014
255 HEPATIC LESION 6 0.0014
256 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
257 MONOCYTE COUNT INCREASED 5 0.0014
258 CHOLESTATIC LIVER INJURY 3 0.0013
259 TONGUE BLISTERING 3 0.0013
260 CARDIAC FAILURE CONGESTIVE 107 0.0013
261 MATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0013
262 HYPOTHYROIDISM 42 0.0013
263 MUSCULOSKELETAL CHEST PAIN 20 0.0013
264 HAEMOPTYSIS 36 0.0013
265 FLANK PAIN 12 0.0013
266 PULMONARY HAEMORRHAGE 10 0.0013
267 PATENT DUCTUS ARTERIOSUS 5 0.0013
268 STREPTOCOCCAL INFECTION 7 0.0013
269 TINNITUS 57 0.0012
270 HAEMATOLOGICAL INFECTION 3 0.0012
271 OXYGEN THERAPY 2 0.0012
272 ESCHERICHIA INFECTION 10 0.0012
273 DEVICE INFUSION ISSUE 3 0.0012
274 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 58 0.0012
275 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
276 PAIN IN JAW 34 0.0012
277 KLEBSIELLA INFECTION 6 0.0012
278 ENDOCARDITIS 6 0.0012
279 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
280 HEPATIC ENZYME INCREASED 77 0.0011
281 AORTIC VALVE STENOSIS 2 0.0011
282 PRODUCTIVE COUGH 53 0.0011
283 VASCULAR DEVICE INFECTION 5 0.0011
284 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
285 OTOTOXICITY 2 0.0011
286 FLUID RETENTION 55 0.0011
287 LIVE BIRTH 9 0.0011
288 SKIN ABRASION 5 0.0011
289 TONGUE OEDEMA 4 0.0010
290 VENTRICULAR SEPTAL DEFECT 6 0.0010
291 MATERNAL DRUGS AFFECTING FOETUS 8 0.0010
292 FINGER DEFORMITY 5 0.0010
293 ATROPHY 2 0.0010
294 GASTRIC DISORDER 35 0.0010
295 DRUG RESISTANCE 26 0.0010
296 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
297 SMALL FOR DATES BABY 5 0.0010
298 ODYNOPHAGIA 6 0.0010
299 OESOPHAGEAL CANDIDIASIS 4 0.0010
300 ARTERIOSPASM CORONARY 4 0.0010
301 TOXIC SKIN ERUPTION 10 0.0010
302 BLOOD COUNT ABNORMAL 15 0.0010
303 NEPHROPATHY TOXIC 11 0.0010
304 RESPIRATORY ARREST 27 0.0010
305 MULTIPLE-DRUG RESISTANCE 3 0.0010
306 HYPOXIA 34 0.0010
307 HEMIPLEGIA 8 0.0010
308 PNEUMONIA ASPIRATION 24 0.0010
309 EOSINOPHIL COUNT INCREASED 8 0.0010
310 CARDIAC FAILURE 77 0.0010
311 LUNG DISORDER 47 0.0010
312 STOMATITIS 58 0.0010
313 LUNG ABSCESS 2 0.0010
314 DILATATION VENTRICULAR 2 0.0010
315 FOETAL DISTRESS SYNDROME 2 0.0009
316 OBESITY 15 0.0009
317 SPLENOMEGALY 11 0.0009
318 C-REACTIVE PROTEIN ABNORMAL 6 0.0009
319 EXPOSED BONE IN JAW 2 0.0009
320 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
321 MIDDLE INSOMNIA 17 0.0009
322 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
323 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
324 RASH MACULO-PAPULAR 20 0.0009
325 POTENTIATING DRUG INTERACTION 3 0.0009
326 MENINGITIS ASEPTIC 4 0.0009
327 HEPATOCELLULAR DAMAGE 2 0.0009
328 ASCITES 26 0.0009
329 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
330 WHEEZING 52 0.0009
331 ABDOMINAL PAIN UPPER 180 0.0009
332 BLOOD CREATININE ABNORMAL 3 0.0009
333 INFUSION SITE INFECTION 2 0.0009
334 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61 0.0009
335 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
336 AGITATION 62 0.0008
337 BRONCHITIS 62 0.0008
338 LIMB OPERATION 4 0.0008
339 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
340 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
341 HYSTERECTOMY 7 0.0008
342 HYPERSENSITIVITY 150 0.0008
343 MIGRAINE 77 0.0008
344 ASTHMA 91 0.0008
345 HYPERNATRAEMIA 4 0.0008
346 OSTEOPOROSIS 33 0.0008
347 HYPERPARATHYROIDISM SECONDARY 2 0.0008
348 PROTEIN TOTAL DECREASED 3 0.0008
349 HEPATIC NECROSIS 3 0.0008
350 HALLUCINATION 60 0.0008
351 TOXIC ENCEPHALOPATHY 4 0.0008
352 CLAVICLE FRACTURE 3 0.0008
353 FOETAL DEATH 4 0.0008
354 APNOEA 6 0.0008
355 MULTIPLE ALLERGIES 6 0.0008
356 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
357 TRICUSPID VALVE INCOMPETENCE 6 0.0008
358 URTICARIA 124 0.0007
359 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
360 BIPOLAR DISORDER 8 0.0007
361 CLONUS 2 0.0007
362 RIB FRACTURE 15 0.0007
363 ECONOMIC PROBLEM 11 0.0007
364 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
365 OSTEOPENIA 11 0.0007
366 ATRIAL SEPTAL DEFECT 6 0.0007
367 GASTROINTESTINAL DISORDER 64 0.0007
368 ABSCESS LIMB 3 0.0007
369 OESOPHAGEAL STENOSIS 2 0.0007
370 UPPER LIMB FRACTURE 14 0.0007
371 LIP PAIN 2 0.0007
372 HERPES VIRUS INFECTION 4 0.0007
373 RHEUMATOID FACTOR POSITIVE 4 0.0007
374 DERMATITIS BULLOUS 5 0.0007
375 URINE ODOUR ABNORMAL 4 0.0007
376 RHEUMATOID ARTHRITIS 77 0.0007
377 BLOOD CREATINE INCREASED 3 0.0007
378 HYPERTENSION 142 0.0007
379 INFUSION SITE REACTION 2 0.0007
380 DEVELOPMENTAL DELAY 6 0.0007
381 SUSPECTED OFF LABEL USE 3 0.0007
382 HYPERCAPNIA 2 0.0007
383 OSTEOMYELITIS 12 0.0007
384 HIDRADENITIS 6 0.0007
385 RENAL FAILURE CHRONIC 5 0.0006
386 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
387 DERMATITIS ALLERGIC 8 0.0006
388 INFUSION SITE PRURITUS 2 0.0006
389 ABDOMINAL DISCOMFORT 106 0.0006
390 PREMATURE BABY 19 0.0006
391 ENDOMETRIOSIS 3 0.0006
392 EOSINOPHILIA 11 0.0006
393 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
394 DRUG ERUPTION 11 0.0006
395 INFLAMMATION 32 0.0006
396 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
397 RESPIRATORY DISTRESS 17 0.0006
398 BACTERIAL SEPSIS 2 0.0006
399 LIMB DISCOMFORT 19 0.0006
400 HYPOVENTILATION 2 0.0006
401 DISEASE RECURRENCE 29 0.0006
402 ASPERGILLUS INFECTION 4 0.0006
403 ANHEDONIA 16 0.0006
404 DEAFNESS NEUROSENSORY 2 0.0006
405 STAPHYLOCOCCAL SEPSIS 3 0.0006
406 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 3 0.0006
407 FACE OEDEMA 10 0.0006
408 COVID-19 PNEUMONIA 7 0.0006
409 WRONG PRODUCT ADMINISTERED 4 0.0006
410 AGRANULOCYTOSIS 11 0.0006
411 CARDIAC MURMUR 5 0.0006
412 TONSILLITIS 3 0.0006
413 APLASTIC ANAEMIA 3 0.0006
414 COUGH 161 0.0006
415 CATATONIA 3 0.0006
416 EAR PRURITUS 2 0.0006
417 SKIN REACTION 8 0.0006
418 HEART DISEASE CONGENITAL 2 0.0006
419 CONJUNCTIVAL HYPERAEMIA 2 0.0006
420 RASH 244 0.0006
421 HAEMOLYTIC ANAEMIA 5 0.0006
422 POOR QUALITY SLEEP 12 0.0006
423 GINGIVITIS 3 0.0006
424 BONE LESION 2 0.0006
425 RASH PUSTULAR 4 0.0005
426 PARADOXICAL DRUG REACTION 2 0.0005
427 INTRACRANIAL PRESSURE INCREASED 3 0.0005
428 NEPHROPATHY 5 0.0005
429 CHRONIC SINUSITIS 2 0.0005
430 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
431 PARANASAL SINUS DISCOMFORT 2 0.0005
432 EAR INFECTION 14 0.0005
433 ACIDOSIS 4 0.0005
434 ENTEROCOLITIS 3 0.0005
435 HYPOVOLAEMIA 3 0.0005
436 RENAL TUBULAR NECROSIS 5 0.0005
437 HEPATOMEGALY 5 0.0005
438 SEPTIC SHOCK 22 0.0005
439 BACTERAEMIA 6 0.0005
440 RENAL CYST 4 0.0005
441 ANXIETY 143 0.0005
442 EXPOSURE VIA BREAST MILK 2 0.0005
443 MUSCLE HAEMORRHAGE 2 0.0005
444 HEPATITIS CHOLESTATIC 3 0.0005
445 CYSTITIS HAEMORRHAGIC 2 0.0005
446 INTERSTITIAL LUNG DISEASE 24 0.0005
447 INGUINAL HERNIA 3 0.0005
448 SHOCK HAEMORRHAGIC 4 0.0005
449 TOOTH ABSCESS 5 0.0005
450 PRODUCT USE ISSUE 92 0.0005
451 CHEST DISCOMFORT 50 0.0005
452 CARDIOMEGALY 6 0.0005
453 ARTHRITIS BACTERIAL 2 0.0005
454 OLIGURIA 3 0.0005
455 RASH ERYTHEMATOUS 23 0.0005
456 PNEUMONITIS 13 0.0005
457 CELLULITIS 24 0.0005
458 ABDOMINAL PAIN LOWER 12 0.0005
459 SKIN PLAQUE 4 0.0005
460 SCRATCH 5 0.0005
461 LIP OEDEMA 2 0.0005
462 MATERNAL EXPOSURE DURING PREGNANCY 42 0.0005
463 AORTIC VALVE INCOMPETENCE 2 0.0005
464 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
465 HYPERHIDROSIS 60 0.0005
466 INFUSION SITE PAIN 6 0.0005
467 MULTI-ORGAN FAILURE 8 0.0005
468 PHARYNGITIS STREPTOCOCCAL 5 0.0005
469 HIP ARTHROPLASTY 7 0.0005
470 ASPIRATION 5 0.0005
471 MALAISE 199 0.0005
472 GINGIVAL SWELLING 2 0.0005
473 APPETITE DISORDER 3 0.0005
474 VISION BLURRED 62 0.0005
475 MENINGITIS 3 0.0004
476 CHOLECYSTITIS CHRONIC 3 0.0004
477 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
478 OEDEMA PERIPHERAL 54 0.0004
479 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
480 PAPILLOEDEMA 2 0.0004
481 PULMONARY EMBOLISM 42 0.0004
482 DRUG EXPOSURE DURING PREGNANCY 15 0.0004
483 ACUTE HEPATIC FAILURE 6 0.0004
484 IMMUNE THROMBOCYTOPENIA 2 0.0004
485 NEPHROGENIC ANAEMIA 2 0.0004
486 ANGIOEDEMA 19 0.0004
487 DYSPNOEA 243 0.0004
488 INJURY 30 0.0004
489 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
490 THROMBOSIS 34 0.0004
491 BRONCHOSPASM 6 0.0004
492 LEUKOPENIA 21 0.0004
493 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
494 FOETAL EXPOSURE DURING PREGNANCY 34 0.0004
495 DRUG-INDUCED LIVER INJURY 13 0.0004
496 BLOOD CREATININE INCREASED 27 0.0004
497 C-REACTIVE PROTEIN INCREASED 15 0.0004
498 PANCYTOPENIA 23 0.0004
499 CONDITION AGGRAVATED 125 0.0004
500 SLEEP DISORDER 29 0.0004
501 ORAL HERPES 8 0.0004
502 BLOOD BILIRUBIN INCREASED 11 0.0004
503 MUSCULOSKELETAL DISCOMFORT 7 0.0004
504 PANCREATIC DISORDER 2 0.0004
505 BREATH SOUNDS ABNORMAL 2 0.0004
506 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
507 ABDOMINAL TENDERNESS 2 0.0004
508 HYPOTONIA 4 0.0004
509 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
510 HYPOTHERMIA 4 0.0004
511 INFUSION RELATED REACTION 26 0.0004
512 ABDOMINAL PAIN 91 0.0004
513 MUSCLE TWITCHING 9 0.0004
514 PNEUMONIA 125 0.0004
515 FAILURE TO THRIVE 2 0.0004
516 NERVOUS SYSTEM DISORDER 12 0.0004
517 BONE DENSITY DECREASED 12 0.0004
518 PARTIAL SEIZURES 2 0.0004
519 CYANOSIS 6 0.0004
520 ADVERSE DRUG REACTION 34 0.0004
521 PNEUMOTHORAX 6 0.0004
522 PREMATURE DELIVERY 6 0.0004
523 IMPAIRED WORK ABILITY 8 0.0004
524 NEOPLASM PROGRESSION 13 0.0004
525 FOOD POISONING 2 0.0004
526 NIGHT SWEATS 12 0.0004
527 INTESTINAL RESECTION 2 0.0004
528 NORMAL NEWBORN 2 0.0004
529 HYPERAESTHESIA 3 0.0004
530 AUTISM SPECTRUM DISORDER 2 0.0004
531 DEAFNESS UNILATERAL 2 0.0004
532 CYTOMEGALOVIRUS INFECTION 6 0.0004
533 DIARRHOEA 233 0.0004
534 GASTRIC ULCER HAEMORRHAGE 2 0.0004
535 ARTHRALGIA 150 0.0004
536 COAGULOPATHY 6 0.0004
537 STEVENS-JOHNSON SYNDROME 8 0.0004
538 BLOOD UREA INCREASED 6 0.0004
539 MALNUTRITION 4 0.0004
540 HAEMODIALYSIS 3 0.0004
541 CANDIDA INFECTION 6 0.0004
542 RENAL FAILURE ACUTE 15 0.0004
543 SINUS DISORDER 7 0.0004
544 MITRAL VALVE INCOMPETENCE 4 0.0004
545 SEASONAL ALLERGY 5 0.0004
546 NEUTROPHILIA 2 0.0004
547 PRURITUS 135 0.0004
548 CORONARY ARTERY BYPASS 2 0.0003
549 HYPERTHYROIDISM 5 0.0003
550 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
551 RESPIRATORY RATE INCREASED 3 0.0003
552 HEPATITIS B 2 0.0003
553 INFECTION 48 0.0003
554 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
555 PATHOGEN RESISTANCE 3 0.0003
556 END STAGE RENAL DISEASE 6 0.0003
557 MYOCARDIAL INFARCTION 57 0.0003
558 LIVER FUNCTION TEST INCREASED 7 0.0003
559 ECZEMA 17 0.0003
560 DEVICE RELATED INFECTION 5 0.0003
561 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
562 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
563 PYREXIA 112 0.0003
564 DEPRESSION 73 0.0003
565 LACERATION 3 0.0003
566 INFUSION SITE SWELLING 2 0.0003
567 CARDIOVASCULAR DISORDER 8 0.0003
568 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
569 SEROTONIN SYNDROME 6 0.0003
570 MOVEMENT DISORDER 10 0.0003
571 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
572 LIVER FUNCTION TEST ABNORMAL 9 0.0003
573 INCOHERENT 2 0.0003
574 HAEMATOMA 8 0.0003
575 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
576 OSTEOARTHRITIS 13 0.0003
577 PHARYNGEAL SWELLING 3 0.0003
578 EXPOSURE DURING PREGNANCY 19 0.0003
579 DYSPHAGIA 29 0.0003
580 HAND DEFORMITY 4 0.0003
581 HYPOGAMMAGLOBULINAEMIA 2 0.0003
582 MULTIPLE FRACTURES 5 0.0003
583 HYPOKALAEMIA 14 0.0003
584 VENTRICULAR TACHYCARDIA 5 0.0003
585 CHRONIC KIDNEY DISEASE 23 0.0003
586 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
587 FEELING ABNORMAL 72 0.0003
588 JOINT RANGE OF MOTION DECREASED 4 0.0003
589 MUSCULOSKELETAL STIFFNESS 26 0.0003
590 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
591 ABNORMAL LOSS OF WEIGHT 2 0.0003
592 TACHYCARDIA 26 0.0003
593 NEPHROTIC SYNDROME 2 0.0003
594 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
595 SKIN LESION 8 0.0003
596 PERITONITIS 6 0.0003
597 HYPERTRANSAMINASAEMIA 2 0.0003
598 CARPAL TUNNEL SYNDROME 4 0.0003
599 LIVER INJURY 7 0.0003
600 LYMPHADENOPATHY 10 0.0003
601 HAND FRACTURE 2 0.0003
602 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
603 BODY HEIGHT DECREASED 3 0.0003
604 SEPSIS 31 0.0003
605 TOOTHACHE 5 0.0003
606 SKIN LACERATION 3 0.0003
607 FAECES SOFT 2 0.0003
608 OESOPHAGITIS 3 0.0003
609 RESTLESSNESS 10 0.0003
610 STAPHYLOCOCCAL INFECTION 9 0.0003
611 MUSCULAR WEAKNESS 31 0.0003
612 GASTROINTESTINAL PAIN 3 0.0003
613 MELAENA 6 0.0003
614 HEART RATE INCREASED 27 0.0003
615 PAIN IN EXTREMITY 80 0.0003
616 ANAPHYLACTIC SHOCK 7 0.0003
617 UNRESPONSIVE TO STIMULI 7 0.0003
618 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
619 FOOT DEFORMITY 3 0.0003
620 NAUSEA 214 0.0003
621 SKIN HAEMORRHAGE 4 0.0003
622 SWELLING 25 0.0003
623 FISTULA 3 0.0003
624 BONE LOSS 4 0.0003
625 BLOOD SODIUM DECREASED 5 0.0003
626 PANCREATITIS 14 0.0003
627 NEUTROPENIA 36 0.0003
628 RENAL FAILURE 35 0.0003
629 SINUSITIS 27 0.0003
630 GASTRIC ULCER 5 0.0003
631 CHOLECYSTECTOMY 3 0.0003
632 HAEMODYNAMIC INSTABILITY 2 0.0003
633 HYPERTHERMIA 2 0.0003
634 VOMITING 123 0.0003
635 SHOCK 6 0.0003
636 PHARYNGEAL OEDEMA 4 0.0003
637 THYROID DISORDER 4 0.0003
638 DRUG INEFFECTIVE 342 0.0003
639 ELECTROLYTE IMBALANCE 3 0.0003
640 OEDEMA 14 0.0003
641 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
642 POST PROCEDURAL HAEMORRHAGE 3 0.0003
643 RENAL DISORDER 12 0.0003
644 HYPOALBUMINAEMIA 2 0.0003
645 SICKLE CELL ANAEMIA WITH CRISIS 4 0.0003
646 FURUNCLE 2 0.0003
647 BLOOD ALBUMIN DECREASED 2 0.0003
648 MYOCLONUS 3 0.0003
649 HYPERLIPIDAEMIA 3 0.0003
650 ABSCESS 4 0.0003
651 HEADACHE 157 0.0003
652 OXYGEN SATURATION DECREASED 14 0.0002
653 ACUTE KIDNEY INJURY 38 0.0002
654 MYASTHENIA GRAVIS 2 0.0002
655 BURSITIS 3 0.0002
656 PULMONARY OEDEMA 11 0.0002
657 DECUBITUS ULCER 2 0.0002
658 BODY TEMPERATURE INCREASED 5 0.0002
659 SMALL INTESTINAL OBSTRUCTION 3 0.0002
660 INJECTION SITE WARMTH 5 0.0002
661 PHARYNGITIS 3 0.0002
662 DRUG LEVEL INCREASED 4 0.0002
663 ANAEMIA 46 0.0002
664 TOOTH EXTRACTION 3 0.0002
665 PULMONARY HYPERTENSION 5 0.0002
666 DEHYDRATION 32 0.0002
667 OFF LABEL USE 209 0.0002
668 INFUSION SITE ERYTHEMA 2 0.0002
669 HEMIPARESIS 4 0.0002
670 FACIAL PARALYSIS 2 0.0002
671 ARTHROPATHY 13 0.0002
672 BLOOD POTASSIUM DECREASED 7 0.0002
673 RASH GENERALISED 6 0.0002
674 DELIRIUM 8 0.0002
675 DISCOMFORT 14 0.0002
676 HYPERKALAEMIA 8 0.0002
677 ORAL CANDIDIASIS 3 0.0002
678 SARS-COV-2 TEST POSITIVE 3 0.0002
679 IMMUNOSUPPRESSION 2 0.0002
680 FLUSHING 23 0.0002
681 PAIN 138 0.0002
682 FACIAL PAIN 2 0.0002
683 JAUNDICE 6 0.0002
684 GOUT 4 0.0002
685 MYOSITIS 2 0.0002
686 MOBILITY DECREASED 16 0.0002
687 SINUS CONGESTION 3 0.0002
688 OROPHARYNGEAL DISCOMFORT 2 0.0002
689 EXOSTOSIS 2 0.0002
690 ERYTHEMA 45 0.0002
691 GRAND MAL CONVULSION 2 0.0002
692 ERYTHEMA MULTIFORME 2 0.0002
693 CHOLELITHIASIS 7 0.0002
694 DYSPEPSIA 21 0.0002
695 SKIN EXFOLIATION 18 0.0002
696 OSTEONECROSIS 7 0.0002
697 ABORTION INDUCED 2 0.0002
698 DYSPNOEA EXERTIONAL 8 0.0002
699 FEBRILE NEUTROPENIA 14 0.0002
700 BLOOD PRESSURE DECREASED 14 0.0002
701 CONVULSION 12 0.0002
702 SUBDURAL HAEMATOMA 3 0.0002
703 BRADYCARDIA 11 0.0002
704 LOCALISED INFECTION 5 0.0002
705 DIZZINESS POSTURAL 2 0.0002
706 FLUID OVERLOAD 3 0.0002
707 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
708 ENCEPHALOPATHY 5 0.0002
709 LABORATORY TEST ABNORMAL 6 0.0002
710 DISORIENTATION 8 0.0002
711 COLON CANCER 3 0.0002
712 IMMUNODEFICIENCY 3 0.0002
713 PREGNANCY 4 0.0002
714 CEREBRAL HAEMORRHAGE 7 0.0002
715 PERIPHERAL SWELLING 30 0.0002
716 CRYING 7 0.0002
717 HERPES ZOSTER 11 0.0002
718 BRAIN FOG 3 0.0002
719 MOUTH ULCERATION 4 0.0002
720 ULCER 3 0.0002
721 DIZZINESS 94 0.0002
722 METABOLIC ACIDOSIS 6 0.0002
723 DISTURBANCE IN ATTENTION 10 0.0002
724 BLOOD POTASSIUM INCREASED 3 0.0002
725 DEEP VEIN THROMBOSIS 12 0.0002
726 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
727 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
728 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
729 METASTASES TO BONE 3 0.0002
730 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
731 PLEURAL EFFUSION 11 0.0002
732 NERVE INJURY 2 0.0002
733 PERICARDITIS 3 0.0002
734 BLISTER 10 0.0002
735 EYE INFECTION 2 0.0002
736 METRORRHAGIA 3 0.0002
737 HAEMOGLOBIN DECREASED 18 0.0002
738 SCAR 3 0.0002
739 EMOTIONAL DISTRESS 21 0.0002
740 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
741 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
742 OROPHARYNGEAL PAIN 16 0.0002
743 CHEST PAIN 32 0.0002
744 MUSCULOSKELETAL PAIN 9 0.0002
745 DYSSTASIA 5 0.0002
746 FATIGUE 133 0.0002
747 INFLUENZA 19 0.0002
748 DRUG INTERACTION 27 0.0002
749 NASAL CONGESTION 10 0.0002
750 CONSTIPATION 37 0.0002
751 SWELLING FACE 11 0.0002
752 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
753 BLOOD IRON DECREASED 2 0.0002
754 RENAL INJURY 5 0.0002
755 CHOLECYSTITIS 2 0.0002
756 MUSCLE RIGIDITY 2 0.0002
757 RENAL IMPAIRMENT 14 0.0002
758 GASTROENTERITIS VIRAL 3 0.0002
759 NEURALGIA 4 0.0002
760 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
761 INJECTION SITE MASS 6 0.0002
762 BACTERIAL INFECTION 3 0.0002
763 INJECTION SITE DISCOLOURATION 2 0.0002
764 HYPOTENSION 32 0.0002
765 DYSARTHRIA 6 0.0002
766 COLITIS 6 0.0002
767 HEAD INJURY 5 0.0002
768 INJECTION SITE IRRITATION 2 0.0002
769 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
770 ACUTE RESPIRATORY FAILURE 3 0.0002
771 HIATUS HERNIA 2 0.0002
772 HAEMORRHOIDS 3 0.0002
773 ARTHRITIS 12 0.0002
774 SKIN DISCOLOURATION 7 0.0002
775 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
776 INJECTION SITE BRUISING 12 0.0002
777 GAIT INABILITY 5 0.0001
778 THROAT TIGHTNESS 4 0.0001
779 PALLOR 4 0.0001
780 IMPAIRED GASTRIC EMPTYING 2 0.0001
781 GINGIVAL BLEEDING 2 0.0001
782 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
783 TOOTH LOSS 3 0.0001
784 DIABETES MELLITUS 11 0.0001
785 MENTAL STATUS CHANGES 4 0.0001
786 DISEASE PROGRESSION 17 0.0001
787 COORDINATION ABNORMAL 2 0.0001
788 WOUND 4 0.0001
789 MASS 2 0.0001
790 COVID-19 25 0.0001
791 KNEE ARTHROPLASTY 3 0.0001
792 HEPATOCELLULAR INJURY 2 0.0001
793 DIALYSIS 2 0.0001
794 HYPOKINESIA 2 0.0001
795 BLOOD PRESSURE INCREASED 21 0.0001
796 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
797 PALPITATIONS 16 0.0001
798 CARDIOMYOPATHY 2 0.0001
799 TRANSAMINASES INCREASED 3 0.0001
800 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
801 THROMBOCYTOPENIA 15 0.0001
802 INFLUENZA LIKE ILLNESS 11 0.0001
803 HEPATIC FAILURE 4 0.0001
804 APHASIA 4 0.0001
805 PRODUCT AVAILABILITY ISSUE 3 0.0001
806 SYNCOPE 13 0.0001
807 FEMUR FRACTURE 4 0.0001
808 RASH PRURITIC 7 0.0001
809 SWOLLEN TONGUE 4 0.0001
810 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
811 LOSS OF CONSCIOUSNESS 16 0.0001
812 HIP FRACTURE 4 0.0001
813 MENTAL IMPAIRMENT 3 0.0001
814 RESPIRATORY FAILURE 9 0.0001
815 PRESYNCOPE 3 0.0001
816 BACK DISORDER 2 0.0001
817 CEREBRAL INFARCTION 3 0.0001
818 NEUTROPHIL COUNT DECREASED 5 0.0001
819 OSTEONECROSIS OF JAW 3 0.0001
820 CARDIAC ARREST 10 0.0001
821 AGEUSIA 3 0.0001
822 VIRAL INFECTION 4 0.0001
823 SKIN DISORDER 4 0.0001
824 URINARY RETENTION 4 0.0001
825 CHILLS 14 0.0001
826 MYALGIA 20 0.0001
827 JOINT SWELLING 14 0.0001
828 RESPIRATORY TRACT INFECTION 3 0.0001
829 MENTAL DISORDER 5 0.0001
830 DEAFNESS 3 0.0001
831 MUCOSAL INFLAMMATION 3 0.0001
832 CONTUSION 11 0.0001
833 FEELING HOT 7 0.0001
834 AMENORRHOEA 2 0.0001
835 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
836 GASTRITIS 3 0.0001
837 METASTASES TO LIVER 2 0.0001
838 HYPOAESTHESIA 17 0.0001
839 ISCHAEMIC STROKE 2 0.0001
840 BACK PAIN 26 0.0001
841 FEAR 3 0.0001
842 HOSPITALISATION 17 0.0001
843 MOOD ALTERED 3 0.0001
844 BONE DISORDER 2 0.0001
845 RHINORRHOEA 7 0.0001
846 CONJUNCTIVITIS 2 0.0001
847 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
848 HYPONATRAEMIA 6 0.0001
849 ASTHENIA 40 0.0001
850 HYPOCALCAEMIA 2 0.0001
851 URINARY TRACT INFECTION 18 0.0001
852 INTENTIONAL DOSE OMISSION 3 0.0001
853 MUSCULOSKELETAL DISORDER 2 0.0001
854 INCREASED APPETITE 2 0.0001
855 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
856 CHOLESTASIS 2 0.0001
857 HERNIA 2 0.0001
858 EAR PAIN 2 0.0001
859 CHOKING 2 0.0001
860 KIDNEY INFECTION 2 0.0001
861 URINARY INCONTINENCE 3 0.0001
862 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
863 HAEMATOCRIT DECREASED 2 0.0001
864 FULL BLOOD COUNT DECREASED 2 0.0001
865 VERTIGO 6 0.0001
866 DYSKINESIA 4 0.0001
867 BONE MARROW FAILURE 2 0.0001
868 EPILEPSY 3 0.0001
869 ILLNESS 10 0.0001
870 ALOPECIA 19 0.0001
871 RHABDOMYOLYSIS 4 0.0001
872 POLLAKIURIA 4 0.0001
873 ABDOMINAL DISTENSION 10 0.0001
874 CARDIO-RESPIRATORY ARREST 4 0.0001
875 EATING DISORDER 2 0.0001
876 JOINT INJURY 2 0.0001
877 EPISTAXIS 7 0.0001
878 RECTAL HAEMORRHAGE 4 0.0001
879 UNEVALUABLE EVENT 7 0.0001
880 ATRIAL FIBRILLATION 9 0.0001
881 PSORIASIS 12 0.0001
882 IMPAIRED HEALING 3 0.0001
883 LIP SWELLING 3 0.0001
884 MEDICATION ERROR 5 0.0001
885 HEPATOTOXICITY 2 0.0001
886 WEIGHT DECREASED 25 0.0001
887 NECK PAIN 5 0.0001
888 GLOSSODYNIA 2 0.0001
889 ORAL PAIN 2 0.0001
890 EYE PAIN 5 0.0001
891 CHROMATURIA 2 0.0001
892 HEART RATE IRREGULAR 2 0.0001
893 NASOPHARYNGITIS 16 0.0001
894 RASH MACULAR 3 0.0001
895 COGNITIVE DISORDER 4 0.0001
896 TREATMENT FAILURE 7 0.0001
897 SOMNOLENCE 17 0.0001
898 BLOOD PRESSURE FLUCTUATION 2 0.0001
899 MYELOSUPPRESSION 3 0.0001
900 CEREBROVASCULAR ACCIDENT 14 0.0001
901 DRUG EFFECT INCOMPLETE 3 0.0001
902 HYPOGLYCAEMIA 4 0.0001
903 SUICIDE ATTEMPT 5 0.0001
904 HYPERGLYCAEMIA 3 0.0001
905 PANIC ATTACK 3 0.0001
906 ACCIDENTAL OVERDOSE 3 0.0001
907 BALANCE DISORDER 7 0.0001
908 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
909 HEPATIC FUNCTION ABNORMAL 3 0.0001
910 HAEMATEMESIS 2 0.0001
911 INSOMNIA 21 0.0001
912 INJECTION SITE SWELLING 6 0.0001
913 HEPATITIS 2 0.0001
914 SEIZURE 9 0.0001
915 JOINT STIFFNESS 2 0.0001
916 LIMB INJURY 2 0.0001
917 BLINDNESS 3 0.0001
918 ABNORMAL DREAMS 2 0.0001
919 DEMENTIA 2 0.0001
920 BURNING SENSATION 5 0.0001
921 ANGINA PECTORIS 2 0.0001
922 INJECTION SITE PAIN 21 0.0001
923 DYSPHONIA 4 0.0001
924 CONFUSIONAL STATE 11 0.0001
925 GAIT DISTURBANCE 13 0.0001
926 DYSGEUSIA 5 0.0001
927 COLITIS ULCERATIVE 3 0.0001
928 WEIGHT INCREASED 15 0.0001
929 THERAPY NON-RESPONDER 3 0.0001
930 LACRIMATION INCREASED 2 0.0001
931 DEATH 57 0.0001
932 ILL-DEFINED DISORDER 4 0.0001
933 SUICIDAL IDEATION 6 0.0001
934 SKIN IRRITATION 3 0.0001
935 INJECTION SITE RASH 2 0.0001
936 BLOOD GLUCOSE INCREASED 12 0.0001
937 OCULAR HYPERAEMIA 3 0.0001
938 NEUROPATHY PERIPHERAL 6 0.0001
939 LACTIC ACIDOSIS 2 0.0001
940 EYE DISORDER 2 0.0001
941 TREMOR 10 0.0001
942 FUNGAL INFECTION 2 0.0001
943 INJECTION SITE REACTION 4 0.0001
944 NIGHTMARE 2 0.0001
945 HAEMORRHAGE 6 0.0001
946 SPEECH DISORDER 3 0.0001
947 FALL 19 0.0001
948 HEART RATE DECREASED 2 0.0001
949 PLATELET COUNT DECREASED 6 0.0001
950 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
951 NO ADVERSE EVENT 10 0.0001
952 TREATMENT NONCOMPLIANCE 3 0.0001
953 MUSCLE SPASMS 10 0.0001
954 HAEMATOCHEZIA 3 0.0001
955 DYSURIA 2 0.0001
956 EYE SWELLING 2 0.0001
957 TOXICITY TO VARIOUS AGENTS 9 0.0001
958 INTESTINAL OBSTRUCTION 2 0.0001
959 EYE IRRITATION 3 0.0001
960 BONE PAIN 3 0.0001
961 MEMORY IMPAIRMENT 7 0.0001
962 PARAESTHESIA 8 0.0001
963 ABNORMAL BEHAVIOUR 2 0.0001
964 IRRITABILITY 3 0.0000
965 OVERDOSE 10 0.0000
966 DEVICE LEAKAGE 2 0.0000
967 AMNESIA 3 0.0000
968 INJECTION SITE PRURITUS 3 0.0000
969 NEPHROLITHIASIS 2 0.0000
970 ADVERSE EVENT 4 0.0000
971 ARRHYTHMIA 2 0.0000
972 COMA 2 0.0000
973 BLOOD GLUCOSE DECREASED 2 0.0000
974 PRODUCT DOSE OMISSION ISSUE 12 0.0000
975 DRY EYE 2 0.0000
976 AGGRESSION 2 0.0000
977 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
978 DECREASED APPETITE 9 0.0000
979 NERVOUSNESS 2 0.0000
980 DRY MOUTH 3 0.0000
981 FLATULENCE 2 0.0000
982 INCORRECT DOSE ADMINISTERED 8 0.0000
983 LETHARGY 2 0.0000
984 DEVICE ISSUE 3 0.0000
985 DEVICE DIFFICULT TO USE 2 0.0000
986 DEVICE MALFUNCTION 2 0.0000
987 HOT FLUSH 2 0.0000
988 INTENTIONAL PRODUCT MISUSE 2 0.0000
989 CARDIAC DISORDER 2 0.0000
990 INJECTION SITE ERYTHEMA 2 0.0000
991 DRY SKIN 2 0.0000